President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...

Prostate cancer is one of the most common cancers diagnosed in men. Although it is the second-leading cause of cancer-related deaths for men in the U.S., it is also highly treatable, especially when ...

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

"Me encontraron càncer en la pròstata," my father told me. "They found cancer in my prostate." As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...

In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer. In an interview with CURE, Dr. David A. Taub ...

Focal cryotherapy is changing prostate cancer care. Dr. Herbert Lepor explains this milestone treatment and what it means for patients. For decades, men diagnosed with prostate cancer faced two ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

For men with a localized recurrence following prostate cancer radiotherapy, salvage treatment with either focal therapy or surgery may offer comparable long-term cancer control, but focal therapy ...

As a cancer researcher who knows very well about the high incidence and decreased survival rates of prostate cancer in the Caribbean, I anguished over these words. Even though I study cancer in my day ...

Prostate cancer treatments are very effective. The five-year survival rate for an early-stage cancer is now over 99 percent. Yet these treatments leave behind side effects. Urinary incontinence, which ...